JPRN-UMIN000038738招募中未知
Phase II study of modified nab-paclitaxel plus gemcitabine in elderly patients over 75 years with unresectable advanced pancreatic cancer - Phase II study of modified nab-paclitaxel plus gemcitabine in elderly patients over 75 years with unresectable advanced pancreatic cancer
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 75years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with contraindication of nab-Paclitaxel+Gemcitabine 2) Second primary malignancy 3) Any patients judged by the investigator to be unfit to participate in the study
研究者
相似试验
招募中
2 期
Phase II study of nab-paclitaxel in combination with carboplatin in patients with refractory small-cell lung cancerRefractory small-cell lung cancerJPRN-UMIN000015565Dokkyo Medical University22
已完成
不适用
A phase II study of nab-paclitaxel for pretreated non-small cell lung canceron-small cell lung cancerJPRN-UMIN000012972Kanagawa Cancer Center30
已完成
2 期
A combination phase II study of paclitaxel and gemcitabine for recurrent or relapsed non-small cell lung cancer previously treated with platinum or docetaxel-based regimenon-small cell lung cancerJPRN-C000000219West Japan Oncology Group80
已完成
2 期
Phase II study of nab-paclitaxel for pretreated NSCLCon-small cell lung cancerJPRN-UMIN000014357Kitasato university hospital, division of respiratory medicine20
尚未招募
不适用
Phase II study of nab-paclitaxel combined with S-1 in patients with early breast cancer:A multicenter clinical trialearly breast cancerJPRN-UMIN000027216The University of Tokushima Graduate School80